|
|
TTD Drug ID:
DNC000364
Drug
Information |
Name | BW A4C | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C17H17NO3/c1-14(19)18(20)12-6-8-15-7-5-11-17(13-15)21-16-9-3-2 -4-10-16/h2-11,13,20H,12H2,1H3/b8-6+ | InChIKey | CEUDWZXMLMKPNN-SOFGYWHQSA-N | Canonical SMILES | CC(=O)N(CC=CC1=CC(=CC=C1)OC2=CC=CC=C2)O | Isomeric SMILES | CC(=O)N(C/C=C/C1=CC(=CC=C1)OC2=CC=CC=C2)O | CAS Number | CAS 106328-57-8 | PubChem Compound ID | CID 6438354. | PubChem Substance ID | SID 700722. | Target | Arachidonate 5-lipoxygenase |  | Inhibitor | [1][2][3][2] | Ref 1 | Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas. Oncogene. 2009 Jul 23;28(29):2690-6. Epub 2009 Jun 8. To Reference | Ref 2 | Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids. Agents Actions. 1991 Mar;32(3-4):289-94. To Reference | Ref 3 | Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189-99. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|